| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0134(199701)27:1<96::AID-PROT10>3.0.CO;2-D |
| P698 | PubMed publication ID | 9037715 |
| P2093 | author name string | Grötzinger J | |
| Rose-John S | |||
| Kurapkat G | |||
| Wollmer A | |||
| Kalai M | |||
| P2860 | cites work | The X-ray structure of a growth hormone-prolactin receptor complex | Q24309612 |
| Human ciliary neurotrophic factor: a structure-function analysis | Q38293879 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 96-109 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Proteins | Q7251514 |
| P1476 | title | The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes | |
| P478 | volume | 27 |
| Q62658923 | A bioactive designer cytokine for human hematopoietic progenitor cell expansion |
| Q30332200 | A structural template for gp130-cytokine signaling assemblies. |
| Q33254113 | Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display |
| Q41048286 | Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions |
| Q41077278 | Analysis of the Mechanism of Action of Anti‐human Interleukin‐6 and Anti‐human Interleukin‐6 Receptor‐neutralising Monoclonal Antibodies |
| Q36605485 | Bioengineered nerve regeneration and muscle reinnervation |
| Q33349514 | Characterization of a potent human interleukin-11 agonist |
| Q35743839 | Cytokine homologs of human gammaherpesviruses |
| Q28145310 | Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis |
| Q73487697 | Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor |
| Q28209470 | Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy |
| Q77470230 | Engineering and use of 32P‐labeled human recombinant interleukin‐11 for receptor binding studies |
| Q45007823 | Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6. |
| Q35323328 | Heart regeneration, stem cells, and cytokines |
| Q41869575 | Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice |
| Q39593637 | High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097 |
| Q37412993 | IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages |
| Q22254431 | Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R |
| Q36495258 | Interleukin-6 and its receptor: from bench to bedside |
| Q24531184 | Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway |
| Q52960794 | Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M. |
| Q83225765 | Kinetics of cytokine receptor trafficking determine signaling and functional selectivity |
| Q41017172 | Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling |
| Q73692223 | Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 Complex |
| Q33737440 | Molecular mechanisms regulating motor neuron development and degeneration. |
| Q33746118 | Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors |
| Q28505506 | Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor |
| Q34073721 | New perspectives on the design of cytokines and growth factors. |
| Q36283919 | Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex |
| Q40028531 | Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors |
| Q22010578 | Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family |
| Q40952738 | Oncostatin M Induces Heat Hypersensitivity by gp130-Dependent Sensitization of TRPV1 in Sensory Neurons |
| Q40320402 | Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism. |
| Q81060793 | Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain |
| Q30322247 | Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6. |
| Q35925860 | Shared cytokine signaling receptors: structural insights from the gp130 system |
| Q24297991 | Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF |
| Q28817043 | Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database |
| Q51787521 | Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. |
| Q38315557 | Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies |
| Q38334627 | The Membrane Proximal Cytokine Receptor Domain of the Human Interleukin-6 Receptor Is Sufficient for Ligand Binding but Not for gp130 Association |
| Q54563031 | The Signal Transducer Gp130 — Bacterial Expression, Refolding and Properties of the Carboxy‐Terminal Domain of the Cytokine‐Binding Module |
| Q41847430 | The amino acid exchange R28E in ciliary neurotrophic factor (CNTF) abrogates interleukin-6 receptor-dependent but retains CNTF receptor-dependent signaling via glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR). |
| Q24297675 | The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane |
| Q38334177 | The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor |
| Q34991808 | The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex |
| Q27617965 | The signal transducer gp130: Solution structure of the carboxy-terminal domain of the cytokine receptor homology region |
| Q34430168 | The therapeutic potential of interleukin-6 hyperagonists and antagonists |
| Q94512263 | Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells |
Search more.